Surgery Partners (SGRY) Short Interest Ratio & Short Volume $23.21 +0.04 (+0.17%) As of 11:14 AM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Surgery Partners Short Interest DataSurgery Partners (SGRY) has a short interest of 9.36 million shares, representing 12.33% of the float (the number of shares available for trading by the public). This marks a -2.09% decrease in short interest from the previous month. The short interest ratio (days to cover) is 9.1, indicating that it would take 9.1 days of the average trading volume of 1.11 million shares to cover all short positions.Current Short Interest9,360,000 sharesPrevious Short Interest9,560,000 sharesChange Vs. Previous Month-2.09%Dollar Volume Sold Short$222.39 millionShort Interest Ratio9.1 Days to CoverLast Record DateMay 31, 2025Outstanding Shares128,160,000 sharesFloat Size75,900,000 sharesShort Percent of Float12.33%Today's Trading Volume41,625 sharesAverage Trading Volume1,112,578 sharesToday's Volume Vs. Average4% Short Selling Surgery Partners? Sign up to receive the latest short interest report for Surgery Partners and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSGRY Short Interest Over TimeSGRY Days to Cover Over TimeSGRY Percentage of Float Shorted Over Time Surgery Partners Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20259,360,000 shares $222.39 million -2.1%12.3%9.1 $23.76 5/15/20259,560,000 shares $226.00 million +0.2%12.6%8.9 $23.64 4/30/20259,540,000 shares $209.40 million +0.3%12.6%9.1 $21.95 4/15/20259,510,000 shares $200.38 million -6.7%12.6%7.2 $21.07 3/31/202510,190,000 shares $242.01 million +0.1%13.5%7.7 $23.75 3/15/202510,180,000 shares $240.25 million +2.0%13.5%8 $23.60 2/28/20259,980,000 shares $240.32 million -2.6%13.2%7.3 $24.08 2/15/202510,250,000 shares $265.17 million +8.5%13.6%7.8 $25.87 1/31/20259,450,000 shares $240.88 million -10.5%12.9%6.5 $25.49 1/15/202510,560,000 shares $213.63 million -4.1%14.3%9.2 $20.23 Get the Latest News and Ratings for SGRY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. 12/31/202411,010,000 shares $233.08 million +1.1%14.9%10.5 $21.17 12/15/202410,890,000 shares $221.72 million -2.7%14.7%10.5 $20.36 11/30/202411,190,000 shares $266.77 million +11.1%15.1%11.8 $23.84 11/15/202410,070,000 shares $231.11 million -0.9%13.6%11.4 $22.95 10/31/202410,160,000 shares $292.61 million +0.4%14.3%12.9 $28.80 10/15/202410,120,000 shares $322.63 million +0.2%14.3%11.5 $31.88 9/30/202410,100,000 shares $325.62 million +1.2%14.3%9.8 $32.24 9/15/20249,980,000 shares $309.38 million -7.9%14.1%8.8 $31.00 8/31/202410,830,000 shares $346.02 million -4.3%15.3%9.7 $31.95 8/15/202411,320,000 shares $339.37 million +3.4%16.0%10.1 $29.98 7/31/202410,950,000 shares $332.44 million -10.8%15.1%10.1 $30.36 7/15/202412,270,000 shares $315.83 million +3.9%16.9%11.5 $25.74 6/30/202411,810,000 shares $280.96 million +6.3%16.3%12.5 $23.79 6/15/202411,105,400 shares $277.64 million +2.2%15.3%12.5 $25.00 5/31/202410,870,000 shares $300.01 million +12.0%15.1%12.5 $27.60 5/15/20249,710,000 shares $262.85 million +8.6%13.5%10.1 $27.07 4/30/20248,940,000 shares $223.05 million +4.0%12.2%9.3 $24.95 4/15/20248,600,000 shares $220.76 million +4.0%11.8%9.4 $25.67 3/31/20248,270,000 shares $246.69 million +2.9%11.3%9.2 $29.83 3/15/20248,040,000 shares $228.90 million +3.6%11.0%8.8 $28.47 2/29/20247,760,000 shares $240.79 million +7.9%10.2%7.9 $31.03 2/15/20247,190,000 shares $249.49 million -7.6%8.9%7.4 $34.70 1/31/20247,780,000 shares $238.77 million +9.4%9.5%7.9 $30.69 1/15/20247,110,000 shares $230.79 million +8.7%8.7%7.2 $32.46 12/31/20236,540,000 shares $209.21 million -8.3%8.0%6.3 $31.99 12/15/20237,130,000 shares $231.37 million +10.7%9.1%7.2 $32.45 11/30/20236,440,000 shares $210.91 million -17.7%9.9%7.4 $32.75 11/15/20237,820,000 shares $243.05 million +5.0%12.0%9.3 $31.08 10/31/20237,450,000 shares $172.32 million +14.1%11.2%9.8 $23.13 10/15/20236,530,000 shares $153.65 million -3.0%9.8%9 $23.53Get Ready for Elon Musk’s BIGGEST Comeback Yet (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again. 9/30/20236,730,000 shares $196.85 million +8.4%10.1%10 $29.25 9/15/20236,210,000 shares $193.81 million -2.2%9.3%8.8 $31.21 8/31/20236,350,000 shares $230.25 million +6.7%9.5%8.3 $36.26 8/15/20235,950,000 shares $198.25 million +10.2%8.9%7.9 $33.32 7/31/20235,400,000 shares $208.60 million -5.9%8.1%7.3 $38.63 7/15/20235,740,000 shares $252.96 million +1.8%8.6%8.2 $44.07 6/30/20235,640,000 shares $253.74 million +7.0%8.5%8.3 $44.99 6/15/20235,270,000 shares $222.76 million +1.7%7.9%8.1 $42.27 5/31/20235,180,000 shares $194.15 million +5.5%8.4%8.9 $37.48 5/15/20234,910,000 shares $177.35 million +4.7%8.0%7.8 $36.12 4/30/20234,690,000 shares $186.01 million -1.7%8.2%7.2 $39.66 4/15/20234,770,000 shares $176.06 million -5.4%8.3%7.5 $36.91 3/31/20235,040,000 shares $173.73 million +9.3%8.8%7.7 $34.47 3/15/20234,610,000 shares $143.19 million -1.3%8.1%7 $31.06 2/28/20234,670,000 shares $156.21 million -1.1%8.1%7 $33.45 2/15/20234,720,000 shares $168.03 million No Change8.2%6.3 $35.60 1/31/20234,720,000 shares $156.70 million -6.4%8.2%5.3 $33.20 1/15/20235,040,000 shares $162.29 million +3.7%8.8%5.5 $32.20 12/30/20224,860,000 shares $135.40 million +13.0%8.5%5.3 $27.86 12/15/20224,300,000 shares $112.02 million -2.3%6.5%4.9 $26.05 11/30/20224,400,000 shares $124.56 million -0.2%8.5%5 $28.31 11/15/20224,410,000 shares $127.89 million -12.3%11.2%5.5 $29.00 10/31/20225,030,000 shares $136.77 million -7.9%12.7%9 $27.19 10/15/20225,460,000 shares $135.14 million -3.0%13.8%10.6 $24.75 9/30/20225,630,000 shares $131.74 million +8.1%14.2%11.8 $23.40 9/15/20225,210,000 shares $152.60 million +4.2%13.2%10.4 $29.29 8/31/20225,000,000 shares $137.65 million +12.6%12.7%9.6 $27.53 8/15/20224,440,000 shares $170.45 million +6.0%11.2%8.7 $38.39 7/31/20224,190,000 shares $165.00 million -1.0%10.6%7.3 $39.38 7/15/20224,230,000 shares $142.76 million +1.4%10.7%7.2 $33.75 6/30/20224,170,000 shares $120.60 million +6.4%10.6%7.4 $28.92 6/15/20223,920,000 shares $112.97 million +21.4%9.9%7.3 $28.82 5/31/20223,230,000 shares $126.62 million -11.8%8.2%6.8 $39.20 5/15/20223,660,000 shares $164.81 million +8.0%9.3%7.7 $45.03 4/30/20223,390,000 shares $173.43 million +13.8%8.6%8 $51.16 4/15/20222,980,000 shares $166.43 million +6.4%7.6%7.5 $55.85 3/31/20222,800,000 shares $154.14 million -11.7%7.3%7.1 $55.05 3/15/20223,170,000 shares $161.26 million +7.5%8.3%8.1 $50.87 2/28/20222,950,000 shares $154.20 million +2.4%7.8%7.7 $52.27 2/15/20222,880,000 shares $145.35 million +32.1%7.6%7.8 $50.47 1/31/20222,180,000 shares $93.02 million +17.8%5.8%5.1 $42.67 1/15/20221,850,000 shares $88.23 million +5.1%4.9%4.6 $47.69 12/31/20211,760,000 shares $94.00 million +17.3%4.6%4.6 $53.41 12/15/20211,500,000 shares $73.59 million +7.9%4.0%3.8 $49.06 11/30/20211,390,000 shares $61.66 million -10.3%4.1%3.5 $44.36 11/15/20211,550,000 shares $79.11 million +3.3%4.5%4 $51.04 10/29/20211,500,000 shares $61.71 million -3.9%4.7%4 $41.14 10/15/20211,560,000 shares $63.93 million -13.3%4.9%4.6 $40.98 9/30/20211,800,000 shares $76.21 million -1.6%5.6%5 $42.34 9/15/20211,830,000 shares $85.61 million +22.8%5.7%4.9 $46.78An AI run of epic proportions is only getting started (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 8/31/20211,490,000 shares $73.31 million +17.3%4.7%3.8 $49.20 8/13/20211,270,000 shares $59.42 million -14.2%4.0%3.3 $46.79 7/30/20211,480,000 shares $80.75 million -17.3%4.6%3.9 $54.56 7/15/20211,790,000 shares $105.48 million -14.8%5.6%4.9 $58.93 6/30/20212,100,000 shares $139.90 million +8.8%6.6%5.9 $66.62 6/15/20211,930,000 shares $125.01 million +7.2%6.0%5.4 $64.77 5/28/20211,800,000 shares $105.35 million +5.3%5.6%5.2 $58.53 5/14/20211,710,000 shares $87.07 million -3.9%13.1%4.6 $50.92 4/30/20211,780,000 shares $89.61 million -3.3%5.6%4.6 $50.34 4/15/20211,840,000 shares $84.27 million -12.4%5.8%3.7 $45.80 3/31/20212,100,000 shares $91.62 million +15.4%6.8%4.3 $43.63 3/15/20211,820,000 shares $76.55 million +7.1%5.9%3.9 $42.06 2/26/20211,700,000 shares $64.35 million +12.6%6.6%3.9 $37.85 2/12/20211,510,000 shares $54.81 million -5.0%5.8%3.7 $36.30 1/29/20211,590,000 shares $58.23 million -3.1%6.1%3.8 $36.62 1/15/20211,640,000 shares $49.51 million No Change7.2%4.9 $30.19 12/31/20201,640,000 shares $46.28 million +3.8%7.2%5 $28.22 12/15/20201,580,000 shares $42.36 million -5.4%6.9%4.4 $26.81 11/30/20201,670,000 shares $43.12 million -2.9%7.3%4.1 $25.82 11/15/20201,720,000 shares $41.09 million -5.0%7.5%4.3 $23.89 10/30/20201,810,000 shares $40.25 million -15.8%7.9%4.6 $22.24 10/15/20202,150,000 shares $50.74 million +2.4%9.4%5 $23.60 9/30/20202,100,000 shares $45.99 million -16.0%9.2%4.3 $21.90 9/15/20202,500,000 shares $57.70 million +3.7%11.0%4.8 $23.08 8/31/20202,410,000 shares $46.01 million -5.5%10.6%4.5 $19.09 8/14/20202,550,000 shares $50.31 million -23.0%11.2%4.3 $19.73 7/31/20203,310,000 shares $50.54 million -9.6%13.4%4.8 $15.27 7/15/20203,660,000 shares $51.02 million +10.2%15.5%4.9 $13.94 6/30/20203,320,000 shares $37.32 million +9.2%14.1%3.3 $11.24 6/15/20203,040,000 shares $37.82 million -10.6%12.9%2.9 $12.44 SGRY Short Interest - Frequently Asked Questions What is Surgery Partners' current short interest? Short interest is the volume of Surgery Partners shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 9,360,000 shares of SGRY short. 12.33% of Surgery Partners' shares are currently sold short. Learn More on Surgery Partners' current short interest. What is a good short interest ratio for Surgery Partners? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SGRY shares currently have a short interest ratio of 9.0. Learn More on Surgery Partners's short interest ratio. Which institutional investors are shorting Surgery Partners? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Surgery Partners: Jane Street Group LLC, HBK Investments L P, and Caption Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Surgery Partners? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.33% of Surgery Partners' floating shares are currently sold short. Is Surgery Partners' short interest increasing or decreasing? Surgery Partners saw a drop in short interest during the month of May. As of May 31st, there was short interest totaling 9,360,000 shares, a drop of 2.1% from the previous total of 9,560,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Surgery Partners' float size? Surgery Partners currently has issued a total of 128,160,000 shares. Some of Surgery Partners' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Surgery Partners currently has a public float of 75,900,000 shares. How does Surgery Partners' short interest compare to its competitors? 12.33% of Surgery Partners' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Surgery Partners: Option Care Health, Inc. (3.57%), Guardant Health, Inc. (7.60%), RadNet, Inc. (9.62%), BrightSpring Health Services, Inc. (14.46%), Sotera Health (8.50%), Privia Health Group, Inc. (3.18%), LifeStance Health Group, Inc. (7.84%), GeneDx Holdings Corp. (14.54%), Veracyte, Inc. (7.15%), Addus HomeCare Co. (4.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Surgery Partners stock? Short selling SGRY is an investing strategy that aims to generate trading profit from Surgery Partners as its price is falling. SGRY shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Surgery Partners? A short squeeze for Surgery Partners occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SGRY, which in turn drives the price of the stock up even further. How often is Surgery Partners' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SGRY, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Option Care Health Short Interest Data Guardant Health Short Interest Data RadNet Short Interest Data BrightSpring Health Services Short Interest Data Sotera Health Short Interest Data Privia Health Group Short Interest Data LifeStance Health Group Short Interest Data GeneDx Short Interest Data Veracyte Short Interest Data Addus HomeCare Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SGRY) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.